Daniel Shin

6PUBLICATIONS

43CO-AUTHORS

Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cell physiology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|Jun 18, 2026

Maintenance Pemetrexed/Pembrolizumab Versus Pembrolizumab in Non-Small Cell Lung Cancer: A Propensity Score-Weighted Analysis.

|Apr 30, 2024

Enhanced CTLA-4 blockade anti-tumor immunity with APG-157 combination in a murine head and neck cancer.

Daniel Sanghoon Shin, Saroj Basak, Mysore S Veena

|Feb 29, 2024

Gigaxonin Suppresses Epithelial-to-Mesenchymal Transition of Human Cancer Through Downregulation of Snail.

Mysore S Veena, Jungmo J Gahng, Mustafa Alani

|Jun 28, 2023

Dysregulation of SWI/SNF Chromatin Remodelers in NSCLC: Its Influence on Cancer Therapies including Immunotherapy.

Yijiang Shi, Daniel Sanghoon Shin

|Oct 15, 2020

Uncoupling interferon signaling and antigen presentation to overcome immunotherapy resistance due to JAK1 loss in melanoma.

Anusha Kalbasi, Mito Tariveranmoshabad, Kevin Hakimi

|Mar 13, 2019

Substitutions that lock and unlock the proton-coupled folate transporter (PCFT-SLC46A1) in an inward-open conformation.

Srinivas Aluri, Rongbao Zhao, Kai Lin

Pageof 1

Frequent Collaborators

Mysore S Veena

Jungmo J Gahng

Mustafa Alani

Albert Y Ko

Saroj K Basak

Isabelle Y Liu

Kimberly J Hwang

Jenna R Chatoff

Natarajan Venkatesan

Marco Morselli

Frequent Collaborators

Mysore S Veena

Jungmo J Gahng

Mustafa Alani

Albert Y Ko